Format

Send to

Choose Destination
Br J Haematol. 2019 Feb;184(4):690-693. doi: 10.1111/bjh.15169. Epub 2018 Mar 12.

Pain and opioid use after reversal of sickle cell disease following HLA-matched sibling haematopoietic stem cell transplant.

Author information

1
Division of Hematology and Oncology, Children's National Medical Center, Washington, DC, USA.
2
The George Washington University School of Medicine, Washington, DC, USA.
3
Sickle Cell Branch, National Heart, Lung and Blood Institute, Bethesda, MD, USA.
4
National Institutes of Health, Bethesda, MD, USA.
5
Pain and Integrative Neuroscience Laboratory, National Center for Complementary and Integrative Health, Bethesda, MD, USA.
6
Ohio State University, Columbus, OH, USA.
7
National Cancer Institute, Rockville, MD, USA.
8
Molecular and Clinical Hematology Branch, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, USA.

KEYWORDS:

haematopoietic stem cell transplant; opioids; pain; sickle cell disease

PMID:
29527656
DOI:
10.1111/bjh.15169

Supplemental Content

Full text links

Icon for Wiley
Loading ...
Support Center